Resilience Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $500K
Latest Deal Amount
  • Investors
  • 2

Resilience Therapeutics General Information

Description

Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions including PTSD and Social Anxiety Disorder. The company's drug discovery engine is focused on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress Related Disorders, providing medical practitioners with first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Boston, MA
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilience Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 03-Mar-2016 $500K 00.000 Completed Startup
1. Angel (individual) 30-Jul-2015 00.000 00.000 00.00 Completed Startup
To view Resilience Therapeutics’s complete valuation and funding history, request access »

Resilience Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Resilience Therapeutics’s complete cap table history, request access »

Resilience Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditi
Drug Discovery
Boston, MA
8 As of 2016
00.000
0000000000 0 00.000

00000 00

t labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
0000000000000
Miramar, FL
00 As of 0000
00000
00 0000-00-00
000000&0 00000

00000 00

im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a
000000000000000
Chatham, NJ
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resilience Therapeutics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Altor BioScience Formerly VC-backed Miramar, FL 00 00000 000000&0 00000
00000 000000000000 Corporation Chatham, NJ 00 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Bethlehem, PA 000.00 0000000000 000.00
000 000000 00000 Private Debt Financed Bresso, Italy 0000 000.00 000000000 000.00
000000000 00000000 Formerly VC-backed Zurich, Switzerland 000 00000 00000000 00000
You’re viewing 5 of 17 competitors. Get the full list »

Resilience Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Retsina Meyer Founder
Gregg Beloff JD Chief Financial Officer
You’re viewing 2 of 6 executive team members. Get the full list »

Resilience Therapeutics Board Members (3)

Name Representing Role Since
Jason Fuller Ph.D Self Board Member 000 0000
William Cowan JD Self Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Resilience Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resilience Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vodia Capital Asset Manager Minority 000 0000 000000 0
Jason Fuller Angel (individual) Minority 000 0000 000000 0
To view Resilience Therapeutics’s complete investors history, request access »